|
The following stocks are the leading risers and fallers on AIM on Monday. ---------- AIM - WINNERS ---------- ITM Power PLC, up 16% at 41.36 pence, 12-month range 25.08p-71.80p. Signs a contract with an unnamed client, who wishes to remain confidential, confirming ITM’s selection as the supplier of more than 300 megawatts of electrolysers for the production of green hydrogen, for use in a power plant in the Asia-Pacific region. The project has received funding approval from the local authorities and remains subject to a final investment decision. ‘We are delighted to work with our customer to advance the engineering, permitting and wider plant integration to drive this large-scale project to FID,’ says ITM Power Chief Executive Officer Dennis Schulz. ---------- Venture Life Group PLC, up 14% at 51.20p, 12-month range 32.00p-58.00p. Agrees the sale of Biokosmes Srl and its contract development and manufacturing business Venture Life Manufacturing AB, as well as some non-core products, for a total of €62.0 million. The deal was made with BioDue Spa, an Italian contract development and manufacturing organisation and portfolio company of investment firm The Riverside Co. This is part of the firm’s effort to streamline its operations and shift away from capital intensive manufacturing operations. It will now direct increased cash flow into the commercialisation, growth and development of its higher margin core brands, such as Balance Activ, Health & Her/Him, and Lift. Venture Life expects to post a one-off profit of around £24.1 million from the disposals in its financial 2025 results. ---------- AIM - LOSERS ---------- Mycelx Technologies Corp, down 13% at 19.99p, 12-month range 19.99p-66.00p. Pretax loss narrows to $2.6 million in 2024 from $3.3 million in 2023, despite revenue falling 55% to $4.9 million from $10.9 million. This is largely driven by a one-off $1.9 million gain on sale of property and equipment in 2024, as well as selling, general and administrative expenses reducing by 18% to $5.5 million from $6.7 million. Cost of goods for the year is down 49% to $3.6 million from $7.0 million. ‘Today, Mycelx stands at an important inflection point in its journey - poised to deliver growth in its core markets, profitability, and delivering the future of clean water globally. Given our continued innovation, refinement, and global deployment of our proprietary technologies, we are now seeing the commercial momentum that has been built from years of foundational work.’ ---------- Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
